Use the Search Fields to Find Information
Page 49 of 375
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
Please use this link to access this publication. ABSTRACT Introduction Targeting CB2 cannabinoid receptor (CB2r) represents a promising approach for the treatment of central nervous
March 25, 2024
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
The CB1 cannabinoid receptor, the main molecular target of endocannabinoids and cannabis active components, is the most abundant G protein-coupled receptor in the mammalian brain.
September 19, 2019
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
The dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA) has been used as an effective drug for treating dopamine depletion-induced Parkinson’s disease (PD). However, long-term administration of L-DOPA produces
The case for medical marijuana in epilepsy
Charlotte, a little girl with SCN1A-confirmed Dravet syndrome, was recently featured in a special that aired on CNN. Through exhaustive personal research and assistance from
The case for assessing cannabidiol in epilepsy
Intractable epilepsies have an extraordinary impact on cognitive and behavioral function and quality of life, and the treatment of seizures represents a challenge and a
The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?
Abstract Marijuana is the most commonly abused illicit drug in the United States (US) and much of the Westernized World with a steadily increasing
February 8, 2022
The cardiac and haemostatic effects of dietary hempseed
Abstract Despite its use in our diet for hundreds of years, hempseed has surprisingly little research published on its physiological effects. This may have
July 27, 2023
The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls
Abstract Background Preclinical and human studies suggest that adolescent cannabis use may be associated with worse cognitive outcomes than adult cannabis use. We investigated the
March 14, 2024
The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD
Dr. Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches targeting the
September 1, 2022
Page 49 of 375